Vaccines and treatments for COVID-19: Vaccine rollout

On this page

Producing a vaccine

Producing a vaccine is complex. It requires significant investments to ensure it can be produced on a large scale with good quality and consistency. Our investments in research will help make sure Canada has faster access to safe and effective vaccines.

Manufacturers manage the process for vaccine production.

Both private and large public investments from governments around the world are being put toward research and development of COVID-19 vaccines.

This partnership between private industry and the public can lead to more affordable and ground-breaking health products for Canada.

Securing enough vaccine

On December 9, 2020, we authorized the first vaccine in Canada for the prevention of COVID-19. Find out about COVID-19 vaccines that are authorized in Canada.

We’re working to make sure everyone in Canada has access to these vaccines as quickly as possible. This includes working with provinces and territories, as they’re responsible for planning and running vaccination programs. The advance purchase agreements we’ve signed will help us reach this goal.

We’re investing in a large selection of vaccines and working hard to make sure vaccine doses are available as quickly as possible after authorization. But it will take time before there’s enough vaccine for everyone in Canada. This is why we've working on recommendations for priority populations for the first doses of the vaccines with the:

The Government of Canada will also provide additional support for:

Vaccination for COVID-19

COVID-19 vaccines approved for use in Canada are free. They're available to priority populations first. They'll then be available to everyone in Canada who is recommended to get the vaccine by federal, provincial and territorial public health authorities.

This applies to:

Vaccination is one of the most effective ways to:

Groups that will get the vaccine first

Priority for early COVID-19 vaccination will be given to the following populations:

As additional COVID-19 vaccine(s) and supplies become available, the following populations should be offered vaccinations:

Local vaccination rollout plans

Provinces and territories have developed detailed vaccination rollout plans for their residents.

Vaccinations in your province or territory

Distributing vaccines

COVID-19 vaccines will be available to everyone in Canada who are recommended to get the vaccine by federal, provincial and territorial public health bodies. Doses of the vaccines will be distributed in Canada in phases, which began in December 2020. Assuming the continued supply of safe and effective vaccines, it’s expected there will be enough vaccines to immunize everyone for whom vaccines are approved and recommended. We anticipate this will be accomplished by September of 2021.

The following table describes the quantities of COVID-19 vaccines that have been delivered to provinces and territories to date. The total vaccine confirmed distribution table will be updated weekly.

Please note: The table below doesn’t presently reflect the full delivery of Moderna vaccine doses forecasted for the week of 11 January, as shipments to provinces and territories are currently ongoing.

Total COVID-19 vaccine confirmed distribution as of January 14, 2021, at 12 pm ET
Vaccine distribution Pfizer/BioNTech Moderna Total
Total distributed in Canada 588,900 176,200 765,100
Newfoundland and Labrador 8,775 2,400 11,175
Prince Edward Island 5,850 2,400 8,250
Nova Scotia 15,600 7,400 23,000
New Brunswick 12,675 5,100 17,775
Quebec 129,675 32,500 162,175
Ontario 224,250 52,800 277,050
Manitoba 26,325 7,300 33,625
Saskatchewan 19,500 4,900 24,400
Alberta 67,275 16,900 84,175
British Columbia 78,975 20,500 99,475
Yukon 0 7,200 7,200
Northwest Territories 0 7,200 7,200
Nunavut 0 6,000 6,000
Federal allocationFootnote 1 0 3,600 3,600


Footnote 1

Federal allocation includes doses for Public Health Agency of Canada (PHAC), the Canadian Armed Forces and Correctional Service Canada

Return to footnote 1 referrer

The following charts describe the allocations of vaccine that are forecasted to be available for provinces and territories over the next number of weeks. These charts are updated as the quantities of available vaccine and the timing of future deliveries are confirmed.

Forecasted allocation of Pfizer-BioNTech COVID-19 vaccine to provinces and territories

The table outlining the forecasted allocation of the Pfizer-BioNTech COVID-19 vaccine to provinces and territories is currently being updated based on changes to manufacturing timelines.

Forecasted allocation of Moderna COVID-19 vaccine to provinces and territories

Distribution location 11-17 Jan 1-7 Feb 22-28 Feb
Total forecasted allocations 171,700 230,400 249,600
Newfoundland and Labrador 2,400 2,800 3,000
Prince Edward Island 1,200 1,200 1,200
Nova Scotia 3,700 5,400 5,900
New Brunswick 2,700 4,300 4,700
Quebec 34,000 47,400 51,800
Ontario 56,700 81,600 89,100
Manitoba 7,400 7,600 8,400
Saskatchewan 5,400 6,500 7,100
Alberta 17,100 24,600 27,000
British Columbia 20,700 28,600 31,000
Yukon 7,200 7,200 7,200
Northwest Territories 7,200 7,200 7,200
Nunavut 6,000 6,000 6,000

Videos, posters and infographics to share

Related links

For health professionals

For industry

Did you find what you were looking for?

What was wrong?

(Don't include any personal information. Note that you will not receive a reply.)
Maximum 300 characters

Thank you for your feedback

Date modified: